Skip to content

Effect Of Phalatrikadi Kwatha In Pandu In Children

Effect Of Phalatrikadi Kwatha In The Management Of Pandu In Children - An Open Clinical Trial

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014424
Enrollment
30
Registered
2018-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pandu

Interventions

Intervention1: phalatrikadi kwatha: Amalaki Haritaki Bibhitaki Amruta Vasa Tikta Bhunimba Nimba AGE KWATHA DOSE (ml)in two divided doses 6-8 year 20 ml 9-11

Sponsors

KAHERs Shri BMK Ayurveda Mahavidyalaya
Lead Sponsor
Dr Vikas kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex between the ages 6 -16 yrs will be selected Patients fulfill diagonistic criteria will be selected Hb % between 8 gm % to 10 gm %

Exclusion criteria

Exclusion criteria: Hematological disorders like sickle cell Anemia hemolytic anemia etc Anemia child who require any form of Emergency management PICA Acute/ chronic severe infections like Pneumonia TB Menstrual history of excessive bleeding Children having any known congenital disorders like CHD etc

Design outcomes

Primary

MeasureTime frame
Phalatrikadi kwatha if proved efficacious would help in treating PANDU efficiently with less untoward effects like constipation, nausea which are usually seen in the commonly used contemporary supplementsTimepoint: Baseline Enrollment Filling CRF Hb% Assessment acc To protocol initiation of intervention 10th day Assessment acc To subjective criteria 20th day Assessment acc To subjective criteria 30th day Withdrawal of intervention Hb% Assessment acc To protocol

Secondary

MeasureTime frame
Phalatrikadi kwatha will be cost effective drug in PANDUTimepoint: Baseline Enrollment Filling CRF Hb% Assessment acc To protocol initiation of intervention 10th day Assessment acc To subjective criteria 20th day Assessment acc To subjective criteria 30th day Withdrawal of intervention Hb% Assessment acc To protocol

Countries

India

Contacts

Public ContactDr Vikas Kumar

KAHERs Shri BMK Ayurveda Mahavidyalaya

drpvsavanur@rediffmail.com9448025369

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026